Greenwich LifeSciences Inc — Quarterly Cash Flow (NASDAQ:GLSI) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Total assets 5.83 M4.09 M2.75 M3.13 M3.81 M Total liabilities 842.38 K1.56 M1.44 M1.69 M1.62 M Total equity 4.98 M2.53 M1.31 M1.44 M2.18 M Total liabilities & shareholders' equities 5.83 M4.09 M2.75 M3.13 M3.81 M Total debt ————— Net debt —————

ニュース

Greenwich LifeSciences、AACR 2026年会議で抄録が採択される

Greenwich LifeSciences abstracts accepted at AACR 2026 meeting

グリニッジ・ライフサイエンス、現金残高1250万ドルを報告

Greenwich LifeSciences reports $12.5 million cash balance

Intel, Oracle among market cap stock movers on Monday

Sarepta Therapeutics, Lands' End, USA Rare Earth, CoreWeave And Other Big Stocks Moving Higher On Monday - Almonty Indus (NASDAQ:ALM), Rich Sparkle Holdings (NASDAQ:ANPA)

Greenwich: GP2 Vaccine Milestone - What FDA Manufacturing Approval Means For Investors

3 Startups Leading American Innovation... and 8 More in the Wings

Greenwich LifeSciences株価、FDAが治験用商業GP2を承認後に急騰

Greenwich LifeSciences stock soars after FDA approves commercial GP2 in trial

FDAがグリニッジのバイオ社の乳がん治療薬GP2の商業ロットを承認

FDA approves commercial GP2 lot for Greenwich’s breast cancer trial